Cargando…
Optimization of personalized therapies for anticancer treatment
BACKGROUND: As today, there are hundreds of targeted therapies for the treatment of cancer, many of which have companion biomarkers that are in use to inform treatment decisions. If we would consider this whole arsenal of targeted therapies as a treatment option for every patient, very soon we will...
Autor principal: | Vazquez, Alexei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651412/ https://www.ncbi.nlm.nih.gov/pubmed/23587292 http://dx.doi.org/10.1186/1752-0509-7-31 |
Ejemplares similares
-
Personalized anticancer therapy selection using molecular landscape topology and thermodynamics
por: Rietman, Edward A., et al.
Publicado: (2016) -
Inference of synergy/antagonism between anticancer drugs from the pooled analysis of clinical trials
por: Kang, Wenfeng, et al.
Publicado: (2013) -
Molecular targeted therapy for anticancer treatment
por: Min, Hye-Young, et al.
Publicado: (2022) -
Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
por: Munnik, Chamoné, et al.
Publicado: (2022) -
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
por: Yadav, Bhagwan, et al.
Publicado: (2014)